Systemic corticosteroids doses in COPD exacerbations treated with non-invasive ventilation

Conclusions: No differences on NIV success according to methylprednisolone doses. Doses 3 1,5 mg/kg/day were used in patients with worst ABG at admission, with a slower pH correction, but with a reduced number of days of admission. No differences in adverse effects were observed.

Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: Rodriguez Melean, N., Lopez Padilla, D., Valenzuela Reyes, P., Banderas Montalvo, M. E., Lopez Yepes, L., Hernandez Both, A., Sayas Catalan, J. Tags: 2.2 Noninvasive Ventilatory Support Source Type: research